Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 04-Oct-24 7:00 PM View:  | Broadwood Partners Lp 10% Owner | Oncocyte Corp (OCX) | 02-Oct-24 | Purchase | 1,315,340 | $2.95 | $3,877,620.00 | 12% 11.17M to 12.49M | |
| 04-Oct-24 7:00 PM View: | Broadwood Partners Lp 10% Owner | Oncocyte Corp (OCX) | 02-Oct-24 | Purchase | -- | -- | -- | 0% 12.49M | |
| 04-Oct-24 7:40 PM View: | James Andrea S. Chief Financial Officer | Oncocyte Corp (OCX) | 02-Oct-24 | Purchase | 33,670 | $2.97 | $99,999.90 | 100% 0 to 33.67K | |
| 15-Apr-24 6:02 AM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 11-Apr-24 | Purchase | 33,898 | $2.95 | $99,999.10 | 67% 50.76K to 84.66K | |
| 15-Apr-24 6:04 AM View: | Riggs Josh CEO and President Director | Oncocyte Corp (OCX) | 11-Apr-24 | Purchase | 3,390 | $2.95 | $10,000.50 | 2948% 0.12K to 3.5K | |
| 15-Apr-24 7:21 PM View: | Broadwood Partners Lp 10% Owner | Oncocyte Corp (OCX) | 11-Apr-24 | Purchase | 2,420,000 | $2.92 | $7,057,690.00 | 33% 7.44M to 9.86M | |
| 15-Apr-24 7:21 PM View: | Broadwood Partners Lp 10% Owner | Oncocyte Corp (OCX) | 11-Apr-24 | Purchase | -- | -- | -- | 0% 9.86M | |
| 03-Jul-23 6:00 PM View: | Gutfreund John Peter | Oncocyte Corp (OCX) | 30-Jun-23 | Disposition (other) | 3,085,050 | -- | -- | (45%) 6.9M to 3.82M | |
| 27-Jun-23 9:30 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 23-Jun-23 | Grant | 30,000 | -- | -- | 3% 985.3K to 1.02M | |
| 27-Jun-23 9:30 PM View: | Silverman Lou Director | Oncocyte Corp (OCX) | 23-Jun-23 | Grant | 25,000 | -- | -- | 399% 6.27K to 31.27K | |
| 27-Jun-23 9:30 PM View: | Kingsley Alfred D Director | Oncocyte Corp (OCX) | 23-Jun-23 | Grant | 20,000 | -- | -- | 4% 563.22K to 583.22K | |
| 27-Jun-23 9:30 PM View: | Last Andrew J. Director | Oncocyte Corp (OCX) | 23-Jun-23 | Grant | 20,000 | -- | -- | 29% 70.17K to 90.17K | |
| 15-Jun-23 8:13 PM View: | Kingsley Alfred D Director | Oncocyte Corp (OCX) | 14-Jun-23 | Private Purchase | 30,000 | $0.21 | $6,447.00 | 6% 533.22K to 563.22K | |
| 07-Apr-23 5:12 PM View: | Pura Vida Investments, LLC 10% Owner | Oncocyte Corp (OCX) | 05-Apr-23 | Private Purchase | 663,000 | $0.30 | $200,027.00 | 5% 14.17M to 14.83M | |
| 05-Apr-23 9:35 PM View: | Broadwood Partners Lp 10% Owner | Oncocyte Corp (OCX) | 03-Apr-23 | Purchase | -- | -- | -- | 0% 100.37M | |
| 05-Apr-23 9:30 PM View: | Gutfreund John Peter Director | Oncocyte Corp (OCX) | 03-Apr-23 | Grant | 705,000 | $0.35 | $249,852.00 | 829% 85.0K to 790.0K | |
| 05-Apr-23 9:29 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 03-Apr-23 | Grant | 141,084 | $0.35 | $50,000.20 | 25% 562.05K to 703.13K | |
| 05-Apr-23 9:30 PM View: | Gutfreund John Peter Director | Oncocyte Corp (OCX) | 03-Apr-23 | Grant | 1,000,000 | $0.35 | $354,400.00 | 127% 790.0K to 1.79M | |
| 05-Apr-23 9:35 PM View: | Broadwood Partners Lp 10% Owner | Oncocyte Corp (OCX) | 03-Apr-23 | Private Purchase | 26,827,600 | $0.30 | $8,093,900.00 | 36% 73.54M to 100.37M | |
| 05-Apr-23 9:29 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 03-Apr-23 | Grant | 282,168 | $0.35 | $100,000.00 | 40% 703.13K to 985.3K | |
| 08-Mar-23 8:54 PM View: | Pura Vida Investments, LLC 10% Owner | Oncocyte Corp (OCX) | 06-Mar-23 | Disposition (other) | 3,890,110 | -- | -- | (22%) 18.06M to 14.17M | |
| 28-Dec-22 4:05 PM View: | Gutfreund John Peter Director | Oncocyte Corp (OCX) | 23-Dec-22 | Private Purchase | 75,000 | $0.33 | $24,727.50 | 100% 0 to 75.0K | |
| 28-Dec-22 4:05 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 23-Dec-22 | Private Purchase | 250,000 | $0.35 | $87,875.00 | 80% 312.05K to 562.05K | |
| 27-Dec-22 6:47 PM View: | Kingsley Alfred D Director | Oncocyte Corp (OCX) | 22-Dec-22 | Private Purchase | 25,000 | $0.28 | $7,125.00 | 5% 508.22K to 533.22K | |
| 22-Dec-22 6:57 PM View: | Ross Douglas T. Former CSO | Oncocyte Corp (OCX) | 21-Dec-22 | Grant | 213,797 | -- | -- | 1052% 20.32K to 234.11K | |
| 20-Dec-22 4:05 PM View: | Paulsen Gisela Former President and COO | Oncocyte Corp (OCX) | 01-Dec-22 | Disposition | 175,000 | -- | -- | (32%) 541.5K to 366.5K | |
| 20-Dec-22 4:05 PM View: | Ross Douglas T. Former CSO. | Oncocyte Corp (OCX) | 01-Dec-22 | Disposition | 150,000 | -- | -- | (88%) 170.32K to 20.32K | |
| 09-Dec-22 8:23 PM View: | Andrews Ronald Asbury Former CEO Director | Oncocyte Corp (OCX) | 01-Dec-22 | Option Exercise | 250,000 | -- | -- | 75% 333.21K to 583.21K | |
| 19-Aug-22 8:00 AM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 17-Aug-22 | Private Purchase | 15,000 | $0.90 | $13,500.00 | 100% 15.0K to 30.0K | |
| 19-Aug-22 8:00 AM View: | Last Andrew J. Director | Oncocyte Corp (OCX) | 17-Aug-22 | Private Purchase | 20,000 | $0.87 | $17,400.00 | 40% 50.17K to 70.17K | |
| 18-Aug-22 4:05 PM View: | Andrews Ronald Asbury President & CEO Director | Oncocyte Corp (OCX) | 16-Aug-22 | Private Purchase | 40,000 | $0.96 | $38,400.00 | 14% 293.21K to 333.21K | |
| 17-Aug-22 8:17 PM View: | Carter Jennifer L. Director | Oncocyte Corp (OCX) | 16-Aug-22 | Purchase | 10,500 | $0.95 | $9,975.00 | 52% 20.0K to 30.5K | |
| 17-Aug-22 8:18 PM View: | Griffith Melinda Director | Oncocyte Corp (OCX) | 16-Aug-22 | Purchase | 10,000 | $1.00 | $10,000.00 | 50% 20.0K to 30.0K | |
| 17-Aug-22 8:15 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 16-Aug-22 | Purchase | 115,523 | $0.97 | $112,057.00 | 69% 166.53K to 282.05K | |
| 17-Aug-22 8:24 PM View: | Ross Douglas T. Chief Scientific Officer | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 150,000 | -- | -- | 738% 20.32K to 170.32K | |
| 17-Aug-22 8:19 PM View: | Gutfreund John Peter Director | Oncocyte Corp (OCX) | 15-Aug-22 | Purchase | 25,000 | $0.93 | $23,250.00 | 250% 10.0K to 35.0K | |
| 17-Aug-22 8:20 PM View: | Kingsley Alfred D Director | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 2% 488.22K to 498.22K | |
| 17-Aug-22 8:20 PM View: | Kingsley Alfred D Director | Oncocyte Corp (OCX) | 15-Aug-22 | Purchase | 10,000 | $0.97 | $9,700.00 | 2% 498.22K to 508.22K | |
| 17-Aug-22 8:15 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 8% 122.05K to 132.05K | |
| 17-Aug-22 8:19 PM View: | John Anish M. Chief Financial Officer | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 150,000 | -- | -- | 100% 0 to 150.0K | |
| 17-Aug-22 8:17 PM View: | Carter Jennifer L. Director | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 17-Aug-22 8:15 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 15-Aug-22 | Purchase | 34,477 | $0.93 | $32,063.60 | 26% 132.05K to 166.53K | |
| 17-Aug-22 8:18 PM View: | Griffith Melinda Director | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 100% 10.0K to 20.0K | |
| 17-Aug-22 8:19 PM View: | Gutfreund John Peter Director | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 100% 0 to 10.0K | |
| 17-Aug-22 8:22 PM View: | Paulsen Gisela President & COO | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 525,000 | -- | -- | 3182% 16.5K to 541.5K | |
| 17-Aug-22 8:21 PM View: | Last Andrew J. Director | Oncocyte Corp (OCX) | 15-Aug-22 | Grant | 10,000 | -- | -- | 25% 40.17K to 50.17K | |
| 28-Jun-22 7:48 PM View: | Pura Vida Investments, LLC 10% Owner | Oncocyte Corp (OCX) | 24-Jun-22 | Sale | 99,386 | $1.03 | $102,635.00 | (< 1%) 16.01M to 15.91M | |
| 19-Jul-22 4:05 PM View: | Last Andrew J. Director | Oncocyte Corp (OCX) | 24-Jun-22 | Option Exercise | 10,000 | -- | -- | 33% 30.17K to 40.17K | |
| 19-Jul-22 4:05 PM View: | Arno Andrew Director | Oncocyte Corp (OCX) | 24-Jun-22 | Option Exercise | 10,000 | -- | -- | 9% 112.05K to 122.05K | |
| 19-Jul-22 4:05 PM View: | Redmond Cavan M. Director | Oncocyte Corp (OCX) | 24-Jun-22 | Option Exercise | 10,000 | -- | -- | 9% 110.86K to 120.86K |
